Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 2/20 | 0.52 |
| ▸ | FGB | P02675 | 1/20 | 0.52 |
| ▸ | MMP14 | P50281 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 6/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2831572 | 0.96 | MAPT (0.54) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL2836129 | 0.96 | TERT (0.48) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL31616869 | 0.92 | MAPT (0.52) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL22410467 | 0.92 | TERT (0.45) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL17717722 | 0.92 | TERT (0.45) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL12658877 | 0.92 | MAPT (0.52) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL30238611 | 0.89 | MAOA (0.52) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL2840051 | 0.89 | MAOA (0.52) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL7496695 | 0.87 | NSD2 (0.57) | NSD2FGBMMP14POLBMEN1 | |
| SCHEMBL18210988 | 0.86 | POLB (0.51) | NSD2FGBMMP14POLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3935111-B1 | CURABLE INK COMPOSITIONS | DOMINO PRINTING SCIENCES PLC (GB) | 2025-07-23 | — | — | EP | disclosed |
| US-12071556-B2 | Curable ink composition | DOMINO PRINTING SCIENCES PLC (GB) | 2024-08-27 | — | — | US | disclosed |
| US-20220145109-A1 | Curable Ink Composition | DOMINO PRINTING SCIENCES PLC (GB) | 2022-05-12 | — | — | US | disclosed |
| EP-3935111-A1 | CURABLE INK COMPOSITIONS | Domino Printing Sciences PLC (GB) | 2022-01-12 | — | — | EP | disclosed |
| WO-2020182640-A1 | CURABLE INK COMPOSITIONS | DOMINO PRINTING SCIENCES PLC (GB) | 2020-09-17 | — | — | WO | disclosed |
| US-20100110242-A1 | Anthraquinone dye containing material, composition including the same, camera including the same, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100110242-A1 | Anthraquinone dye containing material, composition including the same, camera including the same, and associated methods | ACR, PAM, AAAS | NSD2 1116/4885FGB 899/4885MMP14 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.